Susquehanna International Group, LLP Baxter International Inc Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Baxter International Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 107,031 shares of BAX stock, worth $3.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,031

Previous 1,150,592 90.7%

Holding current value

$3.06 Million

Previous $38.5 Million 89.44%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.85 - $40.26 $34.3 Million - $42 Million	-1,043,561 Reduced 90.7%	107,031 $4.06 Million
Q2 2024 Aug 15, 2024	BUY	$32.87 - $43.55 $29.5 Million - $39.1 Million	898,031 Added 355.57%	1,150,592 $38.5 Million
Q1 2024 May 07, 2024	BUY	$37.88 - $43.77 $1.71 Million - $1.97 Million	45,073 Added 21.72%	252,561 $10.8 Million
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $10.1 Million - $12.4 Million	-319,570 Reduced 60.63%	207,488 $8.02 Million
Q3 2023 Nov 14, 2023	BUY	$37.32 - $49.29 $9.62 Million - $12.7 Million	257,733 Added 95.7%	527,058 $19.9 Million
Q2 2023 Aug 11, 2023	SELL	$39.98 - $47.68 $13.9 Million - $16.6 Million	-348,716 Reduced 56.42%	269,325 $12.3 Million
Q1 2023 May 16, 2023	BUY	$37.58 - $52.57 $10.5 Million - $14.6 Million	278,250 Added 81.89%	618,041 $25.1 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $15.2 Million - $17.7 Million	306,345 Added 915.94%	339,791 $17.3 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $9.74 Million - $12.1 Million	-180,807 Reduced 84.39%	33,446 $1.8 Million
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $503,299 - $630,800	7,885 Added 3.82%	214,253 $13.8 Million
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $5.57 Million - $6.48 Million	-72,458 Reduced 25.99%	206,368 $16 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $137,059 - $160,255	-1,838 Reduced 0.65%	278,826 $23.9 Million
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $3.69 Million - $4.18 Million	-50,003 Reduced 15.12%	280,664 $22.6 Million
Q2 2021 Aug 11, 2021	BUY	$80.5 - $88.01 $7.15 Million - $7.82 Million	88,813 Added 36.72%	330,667 $26.6 Million
Q1 2021 May 17, 2021	BUY	$76.38 - $86.03 $9.18 Million - $10.3 Million	120,140 Added 98.71%	241,854 $20.4 Million
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $2.95 Million - $3.23 Million	39,183 Added 47.48%	121,714 $9.77 Million
Q3 2020 Nov 16, 2020	SELL	$78.33 - $90.73 $1.49 Million - $1.72 Million	-18,966 Reduced 18.69%	82,531 $6.64 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $6.76 Million - $8.09 Million	85,938 Added 552.34%	101,497 $8.74 Million
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $13.9 Million - $18.2 Million	-194,677 Reduced 92.6%	15,559 $1.26 Million
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $15.9 Million - $18.3 Million	207,291 Added 7038.74%	210,236 $17.6 Million
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $4.21 Million - $4.65 Million	-51,739 Reduced 94.61%	2,945 $258,000
Q2 2019 Aug 16, 2019	BUY	$73.44 - $82.41 $2.27 Million - $2.55 Million	30,948 Added 130.38%	54,684 $4.48 Million
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $932,173 - $1.05 Million	-12,693 Reduced 34.84%	23,736 $1.94 Million
Q1 2019 May 15, 2019	BUY	$64.48 - $81.31 $1.94 Million - $2.44 Million	30,031 Added 469.38%	36,429 $2.96 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $11,368 - $14,393	-185 Reduced 2.81%	6,398 $421,000
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $104,913 - $124,728	-1,654 Reduced 20.08%	6,583 $486,000
Q1 2018 May 15, 2018	SELL	$62.56 - $72.26 $2.29 Million - $2.64 Million	-36,527 Reduced 81.6%	8,237 $536,000
Q3 2017 Nov 20, 2017	BUY	$59.5 - $64.61 $2.66 Million - $2.89 Million	44,764	44,764 $2.81 Million

Others Institutions Holding BAX

# of Institutions

1,007

Shares Held

450M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.4B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Baxter International Inc Transaction History